TWiV 850: COVID-19 clinical update #96 with Dr. Daniel Griffin
About this episode
In COVID-19 clinical update #96, Daniel Griffin reviews Omicron in South Africa, rapid antigen tests, viral coinfections, isolation and quarantine, saliva preferred for Omicron, risk factors for severe disease in vaccinated, Paxlovid dosing, and long COVID.
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode
- Variant proportions (CDC)
- Omicron in South Africa (JAMA)
- Transmission of SARS-CoV-2 (Ann Int Med)
- Diagnostics for COVID-19 (Lancet)
- Comparison of rapid antigen tests (J Clin Med)
- Rapid antigen tests to reduce isolation (medRxiv)
- Frequency of viral confections (MMWR)
- Isolation and quarantine (CDC)
- Saliva preferred for Omicron (medRxiv)
- Risk factors for severe COVID in vaccinated (MMWR)
- Paxlovid dosing (Pfizer)
- Fatigue and cognitive impairment (Brain, Behavior, Immune)
- Letters read on TWiV 850
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to [email protected]
Get every episode summarized
Each time This Week in Virology publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from This Week in Virology
TWiV 1309: Maybe they're all cancer vaccines
This Week in Virology
TWiV 1308: Clinical update with Dr. Daniel Griffin
This Week in Virology
TWiV 1307: My heart breaks for flu
This Week in Virology
TWiV 1306: Clinical update with Dr. Daniel Griffin
This Week in Virology